TIXIMED Starts a Phase 1 Study of TIX100

TIX100 is a protein which inhibits the action of TIXNP (thioredoxin-interacting protein). It is being developed by the TIXIMED company. TXNIP is elevated in pancreatic islets of people with type-1 diabetes and causes beta cell death and dysfunction. The hope is that inhibiting that protein will protect beta cells and therefore delay or prevent T1D. Anath Shalev, a researcher at the University of…